 CHAM, Switzerland, Nov. 27, 2020 GLOBE NEWSWIRE -- The medical device company Bionovate Technologies Corp adopts a strategic reorientation under new management. Aleksandar Vucak will realign the company as CEO after taking over the majority of the shares of the company, traded on the Nasdaq OTC OTCPK:BIIO. 